Table 1 Significant results from the untargeted metabolomic screen of liver from female Dex exposed offspring compared to their saline controls. Compounds identified as ** indicate metabolites that reached the two cut-off criteria (p < 0.05 and fold change > 2 or < 0.5) while compounds identifed as * indicate metabolites that reach the p < 0.05 criteria only. Upregulations are presented first in descending order with downregulations following (n = 8).
Name | Fold change | p value | Description | Pathway(s) |
---|---|---|---|---|
2,3,4,5-Tetrahydroxypentanal** | 6.228 | 1.31E−07 | Heterosaccharide | Upstream of glycerol metabolism |
Ophthalmic acid** | 4.303 | 3.55E−04 | L-glutamine derivative; analogue of glutathione | Cys and Met metabolism |
Propionylcarnitine** | 2.059 | 0.0269 | Acylcarnitine; a fatty ester lipid molecule | Lipid/fatty acid (FA) metabolism; lipid transport, oxidation of branched chain FAs |
Adenosine* | 1.970 | 0.0047 | Component of DNA and RNA; neurotransmitter and potent vasodilator | Purine metabolism; cAMP signaling pathway |
Adenine* | 1.911 | 0.0109 | Purine nucleobase | Purine metabolism |
Creatinine* | 1.905 | 0.0012 | Product of creatine phosphate | Arg and Pro metabolism |
Spermidine* | 1.869 | 8.44E−05 | Polyamine; helps stabilize membranes and nucleic acid structures | Arg, Pro, Ala, and glutathione metabolism; bile secretion |
Glutathione disulfide* | 1.775 | 0.0416 | Oxidized form of glutathione | Glutathione metabolism |
Choline* | 1.683 | 0.0221 | Precursor of acetylcholine | Many pathways |
L-(−)-methionine* | 1.667 | 0.0493 | Essential amino acid | Cys and Met metabolism |
Hypoxanthine* | 1.634 | 0.0354 | Purine derivative | Purine metabolism |
L-(+)-Ergothioneine* | 1.558 | 0.0385 | Metabolite of His; antioxidant properties | Histidine metabolism |
3-hydroxyisovaleryl carnitine* | 1.486 | 0.0186 | Intermediate of FA oxidation | Lipid/FA metabolism; lipid transport |
Nicotinamide* | 1.464 | 0.0433 | Pyridine derivative; precursor for NAD + /NADH and NADP + /NADPH | Nicotinate/Nicotinamide metabolism |
Phosphatidylethanol-amine (18:2/18:2)** | 0.006 | 6.18E-05 | Phosphatidylethanol-amine lipid | Glycerophospholipid metabolism; lipid transport |
Lactosylceramide (d18:1/12:0)** | 0.216 | 0.0018 | Important ceramide; assists in stabilizing plasma membrane | Phospholipid/ sphingolipid and lipid/FA metabolism; lipid transport |
Linolenelaidic acid** | 0.308 | 0.0116 | Polyunsaturated omega-6 long chain fatty acid | Lipid/FA metabolism; lipid transport |
Phosphatidylserine (14:0/14:1)** | 0.491 | 0.0012 | Phosphatidylserine lipid | Glycerophospholipid and lipid metabolism; lipid transport |